Please Wait
Applying Filters...
menu
    • menu
    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Cemiplimab

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2Sanofi-Aventis Canada Inc.

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Sanofi-Aventis Canada Inc.

    Cemiplimab
    arrow
    CPHI Shenzhen
    Not Confirmed

    Sanofi-Aventis Canada Inc.

    Country
    arrow
    CPHI Shenzhen
    Not Confirmed

    Patent Expiration Date : 2035-01-23

    Date Granted : 2023-09-19

    Cemiplimab

    Brand Name : LIBTAYO

    Patent Number : 2936075

    Filing Date : 2015-01-23

    Strength per Unit : 350mg / 7mL

    Dosage Form : SOLUTION

    Human Or VET : Human

    Route of Administration : INTRAVENOUS

    Patent Expiration Date : 2035-01-23

    Date Granted : 2023-09-19

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Sanofi-Aventis Canada Inc.

    Cemiplimab
    arrow
    CPHI Shenzhen
    Not Confirmed

    Sanofi-Aventis Canada Inc.

    Country
    arrow
    CPHI Shenzhen
    Not Confirmed

    Patent Expiration Date : 2035-01-23

    Date Granted : 2023-09-19

    Cemiplimab

    Brand Name : LIBTAYO

    Patent Number : 2936075

    Filing Date : 2015-01-23

    Strength per Unit : 250mg / 5mL

    Dosage Form : SOLUTION

    Human Or VET : Human

    Route of Administration : INTRAVENOUS

    Patent Expiration Date : 2035-01-23

    Date Granted : 2023-09-19

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF